1. 星野純一, 山縣邦弘.REACH-J研究とCKDopps.日腎会誌.2021,63(2):219-224.
2. 西 愼一.マージナルドナーの術前・術後管理.腎と透析.2020, 89, 919-924.
3. 西 愼一.腎疾患の検査の進め方.臨牀と研究.2020, 97, 649-654.
4. 上野幸司, 河西由香里, 大山彩香, 白石 武, 菊池孝典, 吉村 章, 山本尚史, 齋藤孝子, 井上 真, 椎崎和弘, 齋藤 修, 長田太助. InBody-S20使用における透析患者の標準化Dry weight算出の試み. 医工学治療. 2020,32(1): 26-33.
5. 武藤重明, 菅生太朗, 八木澤 隆, 長田太助. 症例から学ぶマージナルドナーの術前評価と術後フォローアップ. 日本臨床腎移植学会雑誌.2020,8(1): 33-41.
6. 大西 央, 小林高久, 今井利美, 永山 泉, 川又 睦, 若林奈津子, 秋元 哲, 齋藤 修, 武藤重明, 長田太助. 重篤な心停止後症候群に至った後も維持血液透析を継続した2症例. 臨床透析.2020,35(9): 1219.
7. Hatano Y, Yano Y, Fujimoto S, Sato Y, Iseki K, Konta T, Moriyama T, Yamagata K, Tsuruya K, Narita I, Kondo M, Kasahara M, Shibagaki Y, Asahi K, Watanabe T. The Population-Attributable Fraction for Premature Mortality Due to Cardiovascular Disease Associated With Stage 1 and 2 Hypertension Among Japanese. Am J Hypertens. 2021, 34(1):56-63. doi: 10.1093/ajh/hpaa128. PMID: 32756946.
8. Wakasugi M, Narita I, Iseki K, Asahi K, Yamagata K, Fujimoto S, Moriyama T, Konta T, Tsuruya K, Kasahara M, Shibagaki Y, Kondo M, Watanabe T. The Effect of CKD on Associations between Lifestyle Factors and All-cause, Cancer, and Cardiovascular Mortality: A Population-based Cohort Study. Intern Med. 2021, doi: 10.2169/internalmedicine.6531-20. Epub ahead of print. PMID: 33583896.
9. Iwasaki M, Kudo A, Asahi K, Machii N, Iseki K, Satoh H, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T, Shimabukuro M. Fast walking is a preventive factor against new-onset diabetes mellitus in a large cohort from a Japanese general population. Sci Rep. 2021 ,11(1):716. doi: 10.1038/s41598-020-80572-y. PMID: 33436978; PMCID: PMC7804125.
10. Tsuruya K, Hayashi T, Yamamoto H, Hase H, Nishi S, Yamagata K, Nangaku M, Wada T, Uemura Y, Ohashi Y, Hirakata H; RADIANCE-CKD Study Investigators. Renal prognoses by different target hemoglobin levels achieved by epoetin beta pegol dosing to chronic kidney disease patients with hyporesponsive anemia to erythropoiesis-stimulating agent: a multicenter open-label randomized controlled study. Clin Exp Nephrol. 2021 ,25(5):456-466. doi: 10.1007/s10157-020-02005-4. PMID: 33411115.